Lexaria Bioscience Corp (LEXX)

Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	0.02	-	0.17	0.17
Cost Of Revenue	-	-	-	-	-
Gross Profit	100.00%-	0.02	-	0.17	0.17
	35.46%1.99	1.47	1.57	2.86	3.92
Research and Development	104.22%0.97	0.48	0.67	1.88	2.72
Depreciation and Amortization	0.56%0.02	0.02	0.02	0.02	0.03
Operating Income/Loss	37.32%-1.99	-1.45	-1.57	-2.69	-3.75
Nonoperating Income/Loss	52.69%0.00	0.00	-0.02	-0.01	-0.04
Income/Loss From Continuing Operations Before Tax	-1.99	-	-1.60	-2.70	-3.79
Income Tax Expense/Benefit	99.46%0.00	0.00	0.00	-	-
	37.19%-1.99	-1.45	-1.60	-2.70	-3.79
Attributable To Parent	37.33%-1.99	-1.45	-1.60	-2.70	-3.79
Attributable To Noncontrolling Interest	35.38%-0.00	-0.00	-0.00	-0.00	-0.00
Diluted Average Shares	1.48%24.81	24.44	21.38	0.53	18.30
Diluted Earnings Per Share	33.33%-0.08	-0.06	-0.07	-0.13	-0.21